Anales de la RANM

248 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 LA EDAD DEL DONANTE EN EL TRASPLANTE HEPÁTICO Carlos Jiménez Romero An RANM · Año 2019 · número 136 (03) · páginas 239 a 248 nor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005;140:273-277. 21. Grande L, Matus D, Rimola A, et al. Expanded liver donor age over 60 years for liver transplantation. Clin Transplant 1998;12:297-301. 22. Rodríguez F, Jiménez C, Romano D, et al. Orthotopic liver transplantation with 100 hepatic allografts fromdo- nors over 60 years old. Transplant Proc 2002;34:233-234. 23. Gastaca M, Valdivieso A, Pijoan J, et al. Donors older than 70 years in liver transplantation. Transplant Proc 2005;37:3851-3854. 24. Zapletal C, Faust D, Wullstein C, et al. Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 2005;37:1182-1185. 25. Segev DR, Maley WR, Simpkins CE, et al. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 2007;46:1907-1918. 26. Cescon M, Grazi GL, Cucchetti A, et al. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl 2008;14:672-679. 27. Mooney H, Roberts R, Cooksley WGE, Halliday JW, Powell LW. Alterations in the liver with ageing. Clin Gastroenterol 1985; 14:757-71. 28. Schmucker DL. Age-related changes in liver structure and function: Implications for disease? Exp Gerontol 2005;40:650-659. 29. Winne HA, James OFW. The ageing liver. Comentary. Age Ageing 1990; 19:1-3. 30. Jiménez C, Moreno E, Colina F, et al. Use of octogena- rian livers safely expands the donor pool. Transplanta- tion 1999; 68:572-576. 31. Winne HA, Cope LH, Mutch E, Rawlins MD, Woo- dhouse KW, James OFW. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989;9:297-301. 32. Jung T, Bader N, Grune T. Lipofuscin: formation, dis- tribution, and metabolic consequences. Ann NY Acad Sci 2007;1119:97-111. 33. James OFW. Gastrointestinal and liver function in old age. Clin Gastroenterol 1983; 12:671-89. 34. McLean AJ, Cogger VC, Chong GC, et al. Age-related pseudocapillarization of the human liver. J Pathol 2003;200:112-117. 35. Watanabe T, Tanaka Y. Age-related alterations in the size of human hepatocytes. A study of mononuclear and binucleate cells. Virchows Arch (Cell Pathol) 1982;39:9- 20. 36. Aikata H, Takaishi H, Kawakami Y, et al. Telomere re- duction in human liver tissues with age and chronic in- flammation. Exp Cell Res 2000;256:578-582. 37. Le Couteur DGL, Warren A, Cogger VC, et al. Old age and the hepatic sinusoid. Anat Rec 2008;291:672-683. 38. Regev A, Schiff ER. Liver disease in the elderly. Gas- troenterol Clin North America 2001;30:547-563. 39. LandowneM, Stanley J. Aging of the cardiovascular sys- tem. In: Shock NW, editor. Aging some social and bio- logical aspects. Washington: American Association for the advancement of the Science 1960;159-187. 40. Bender AD. The effect of increasing age on the distri- bution of peripheral blood in man. J Am Geriatr Soc 1965;13:192-198. 41. DeBakey ME, Lawrie GM, Glaeser DH. Patterns of atheroesclerosis and their surgical significance. Ann Surg 1985;101:115-131 42. Sato T, Miwa T, Tauchi H. Age changes in the human liv- er of the different races. Gerontologia 1970;16:368-380. 43. Findor J, Pérz V, Igartua EB, Giovanetti M, Fiovaranti N. Structure and ultrastructure of the liver in aged persons. Acta Hepatogastroenterol 1973;20:200-204. 44. Popper H. Coming of age. Hepatology 1985;5:1224- 1226. 45. Schmucker DL, Sanchez H. Liver regeneration and ag- ing: A current perspective. Curr Gerontol Geriatr Res 2011;2011:526379:1-8 46. Le Couteur DG, Rivory LP, Pond SM. The effects of ag- ing nutritional state on hipoxia-reoxygenation injury in the perfused rat liver. Transplantation 1994;54:531-536. 47. Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl 2008;14:1694-1707. 48. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk fac- tors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 1993;55:807- 813. 49. Mor E, KlintmalmGB, Gonwa TA, et al.The use of mar- ginal donors for liver transplantation. Transplantation 1992; 53:383-386. 50. Mirza DF, Gunson BK, Da Silva RF, Mayer AD, Buckels JA, McMaster P. Policies in Europe on marginal quality donor livers. Lancet 1994;344:1480-1483. 51. Cameron AM, Ghobrial RM, Yersiz H, et al. Optimal utilization of donor grafts with extended criteria. A single-center experience in over 1000 liver transplants. Ann Surg 2006;243:748-755. 52. Briceño J, Solórzano G, Pera C. A proposal for scor- ing marginal liver grafts. Transpl Int 2000;13 (Suppl 1):S249-S252. 53. Nardo B, Masetti M, Urbani L, et al. Liver transplanta- tion from donors aged 80 years and over: pushing the limit. Am J Transplant 2004; 4:1139-1147. 54. Kim DY, Cauduro SP, Bohorquez HE, Ishitani MB, Ny- berg SL, Rosen CB. Routine use of livers from deceased donors older than 70: is it justified? Transplant Int 2005; 18:73-77. 55. Jiménez-Romero C, Clemares M, Manrique A, García- Sesma A, Calvo J, Moreno E. Long-term results us- ing old liver grafts for transplantation: sexagenarian versus liver donors older than 70 years. World J Surg 2013;37:2211-2221. DECLARACIÓN DE TRANSPARENCIA El autor/a de este artículo declara no tener ningún tipo de conflicto de intereses respecto a lo expuesto en la presente revisión. Si desea citar nuestro artículo: Jiménez-Romero C. La edad del donante en el transplante hepático ANALES RANM [Internet]. Real Academia Nacional de Medicina de España; An RANM · Año 2019 · número 136 (03) · páginas 239– 248 DOI: 10.32440/ar.2019.136.03. rev02 Puede encontrar la bibliografía completa de este artículo en https://analesranm.es/